Drug intelligence / Profile preview

sodium nitrite + sildenafil

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

**Sodium nitrite + sildenafil** is a combination of two drugs: sodium nitrite, an inorganic compound used medically as an antidote or vasodilator, and sildenafil, a phosphodiesterase type 5 inhibitor (PDE5 inhibitor) primarily used for erectile dysfunction and pulmonary arterial hypertension. Both drugs act as vasodilators but through distinct mechanisms. Sodium nitrite acts as a nitric oxide donor, increasing nitric oxide in the blood and relaxing vascular smooth muscle via the nitric oxide–cGMP pathway. Sildenafil inhibits phosphodiesterase type 5, prolonging cGMP activity and enhancing vasodilation. When used in combination, these drugs can have additive effects on vasodilation, leading to significant lowering of blood pressure. Due to this synergy, co-administration is generally contraindicated, as it can result in dangerously low blood pressure and cardiovascular risk. Documented uses include experimental settings for acute pulmonary hypertension and pulmonary embolism, but the combination is not approved for routine clinical use and is associated with serious safety warnings.[1][3][4][5][6]

02

Targets

PDE5 (Phosphodiesterase 5A)sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on sodium nitrite + sildenafil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium nitrite + sildenafil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call